# CORRESP — Transcode Therapeutics, Inc.  (RNAZ)  (CIK 0001829635)

> <strong>Transcode Therapeutics, Inc.  (RNAZ)  (CIK 0001829635) → SEC staff</strong> · filed 2026-05-15 · ticker RNAZ · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-26-062704
- **Form:** CORRESP
- **Filer:** Transcode Therapeutics, Inc.  (RNAZ)  (CIK 0001829635)
- **CIK:** 0001829635
- **Ticker:** RNAZ
- **Filed:** 2026-05-15
- **SIC industry:** 2834
- **HQ:** Boston, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1829635/000110465926062704/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1829635&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Transcode Therapeutics, Inc.  (RNAZ)  (CIK 0001829635)

- CORRESP — 2026-05-15 — /comment-letter/0001104659-26-062701
- UPLOAD — 2026-05-06 — /comment-letter/0000000000-26-004640
- UPLOAD — 2026-05-06 — /comment-letter/0000000000-26-004639
- CORRESP — 2025-12-18 — /comment-letter/0001104659-25-122526

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Transcode Therapeutics, Inc.  (RNAZ)  (CIK 0001829635) (CIK 0001829635), filed 2026-05-15, accession 0001104659-26-062704. Retrieved via MORVS 2026-11-21 from https://api.morvs.ai/comment-letter/0001104659-26-062704.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
